By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Amunix, Inc. 

500 Ellis Street
Suite B
Mountain View  California  94043  U.S.A.
Phone: 650-428-1800 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





Company News
Amunix, Inc. Congratulates Versartis, Inc. (VSAR) On Its Positive Phase 2a Results With VRS-317 6/30/2014 11:13:03 AM
Amunix, Inc. Presents XTEN Half-Life Extension Technology At Next Generation Protein Therapeutics Summit 6/6/2014 8:44:39 AM
Amunix, Inc. To Present Unpublished Data At Next Generation Protein Therapeutics Summit 5/28/2014 11:22:42 AM
Biogen Idec, Inc. (California) (BIIB) Signs License Agreement With Amunix, Inc. For XTENylated Factor VIII 4/21/2014 10:03:52 AM
Amunix, Inc. Announces Expansion To Licensing Agreement With Janssen Biotech Inc. (JNJ) For Its Proprietary XTEN Technology 1/7/2014 9:44:17 AM
Amunix, Inc. Announces Update to Licensing Agreement With Janssen Biotech Inc. for Its Proprietary XTEN Technology 8/14/2013 9:37:58 AM
Preclinical Data From Biogen Idec, Inc. (Massachusetts) (BIIB)-Amunix, Inc. Partnership Presented at ISTH Congress 7/2/2013 10:40:49 AM
Amunix, Inc. Announces Licensing Agreement for Its Proprietary XTEN Technology 1/22/2013 9:54:35 AM
Amunix, Inc. Signs Research Collaboration With Biogen Idec, Inc. (California) (BIIB) for Next Generation Long-Lasting Blood Factor Products 4/13/2011 9:21:33 AM
Index Ventures and Amunix, Inc. Invest in New Company, Diartis Pharmaceuticals 2/16/2011 8:26:02 AM
12
//-->